Global Virtual Congress
Prosto 2026 – Global Virtual Congress on Prostate Cancer
Overview
Event Highlights
- Advancing screening, early diagnosis, and multidisciplinary treatment across all stages of prostate cancer.
- Integrating advanced imaging, molecular testing, PSMA-targeted therapies, and precision medicine into clinical practice.
- Connecting global experts to improve survival, quality of life, and long-term prostate cancer care.
Date / Time
Nov 13, 2026
Save to
Prosto 2026 is a global virtual medical congress dedicated entirely to prostate cancer, focusing on screening, early diagnosis, multidisciplinary treatment strategies, precision oncology, and future directions in disease management and survivorship.
The OncoDaily How I Treat series returns with a dedicated global summit on prostate cancer treatment, bringing together leading international experts to explore the latest advances in the management of prostate cancer in 2026.
Prostate cancer remains the second most common cancer in men worldwide, with approximately 1 in 8 men diagnosed during their lifetime. According to the World Health Organization, cancer continues to represent one of the leading global health challenges. In the United States alone, an estimated 313,780–333,830 new cases and 35,770–36,320 deaths occur annually. Patients with localized disease continue to demonstrate excellent outcomes, while those with metastatic prostate cancer face more complex treatment challenges. Despite this, long-term survival rates continue to improve significantly due to advances in early detection, imaging, systemic therapy, and multidisciplinary care.
At the same time, the therapeutic landscape is rapidly evolving. The integration of next-generation androgen receptor pathway inhibitors, PSMA-targeted therapies, advanced molecular imaging, and biomarker-guided precision medicine is transforming how prostate cancer is managed across all stages while improving both survival and quality of life.
Scientific Program Overview
Prosto 2026 will explore the full clinical spectrum of prostate cancer, focusing on practical, evidence-based management strategies in 2026.
The program will cover contemporary approaches to localized, advanced, and metastatic disease, including PSMA PET imaging, radioligand therapy, next-generation androgen receptor pathway inhibitors, precision oncology, and biomarker-driven treatment strategies.
The congress will also highlight multidisciplinary collaboration, survivorship, quality of life, and global disparities in access to care, bringing together international experts through the OncoDaily How I Treat series to translate emerging science into real-world clinical practice.
Bringing together leading experts across medical oncology, urology, radiation oncology, radiology, pathology, and nuclear medicine, Prosto 2026 aims to translate emerging science into actionable, real-world treatment strategies that improve outcomes for patients worldwide.
Scientific Leadership
To be announced
About the Congress
Prosto 2026 is a global virtual medical congress dedicated to advancing the diagnosis, treatment, and long-term management of prostate cancer. The congress will focus on screening, early detection, multidisciplinary treatment strategies, precision oncology, survivorship, and future directions in prostate cancer care.
Through expert-led presentations, case-based discussions, and international perspectives, the program will explore practical approaches to managing prostate cancer across all stages of disease, from localized and high-risk disease to advanced and metastatic prostate cancer.
Key topics will include prostate cancer screening, modern imaging, active surveillance, surgery, radiation therapy, systemic treatments, molecular and genetic testing, next-generation hormonal therapies, PSMA-targeted treatments, supportive care, survivorship, quality of life, and emerging clinical research.
By bringing together leading experts from different countries and healthcare systems, the congress aims to strengthen multidisciplinary collaboration, share real-world clinical experience, and support the development of more personalized and effective approaches to prostate cancer care worldwide.
Who Should Attend?
This congress is designed for medical oncologists, urologists, urologic oncologists, radiation oncologists, surgical oncologists, radiologists, pathologists, nuclear medicine specialists, oncology nurses, oncology pharmacists, genetic counselors, researchers, palliative care professionals, patient advocates, and all healthcare professionals involved in the diagnosis, treatment, and long-term care of patients with prostate cancer.
Why To Attend?
Prosto 2026 will provide a global platform for leading experts and multidisciplinary cancer care professionals to discuss the latest developments in prostate cancer screening, diagnosis, treatment, and survivorship.
Participants will gain practical insights into multidisciplinary decision-making, learn from real-world clinical experiences, explore biomarker-guided and personalized treatment approaches, and better understand the role of advanced imaging and innovative therapies across different stages of prostate cancer.
The congress will also offer opportunities to connect with international experts and join a global conversation focused on improving survival, quality of life, and long-term outcomes for patients with prostate cancer
Scientific Program Overview
Prosto 2026 will explore the full clinical spectrum of prostate cancer, focusing on practical, evidence-based management strategies in 2026.
The program will cover contemporary approaches to localized, advanced, and metastatic disease, including PSMA PET imaging, radioligand therapy, next-generation androgen receptor pathway inhibitors, precision oncology, and biomarker-driven treatment strategies.
The congress will also highlight multidisciplinary collaboration, survivorship, quality of life, and global disparities in access to care, bringing together international experts through the OncoDaily How I Treat series to translate emerging science into real-world clinical practice.
Bringing together leading experts across medical oncology, urology, radiation oncology, radiology, pathology, and nuclear medicine, Prosto 2026 aims to translate emerging science into actionable, real-world treatment strategies that improve outcomes for patients worldwide.
Scientific Leadership
To be announced
Speakers
To be announced
About the Congress
Prosto 2026 is a global virtual medical congress dedicated to advancing the diagnosis, treatment, and long-term management of prostate cancer. The congress will focus on screening, early detection, multidisciplinary treatment strategies, precision oncology, survivorship, and future directions in prostate cancer care.
Through expert-led presentations, case-based discussions, and international perspectives, the program will explore practical approaches to managing prostate cancer across all stages of disease, from localized and high-risk disease to advanced and metastatic prostate cancer.
Key topics will include prostate cancer screening, modern imaging, active surveillance, surgery, radiation therapy, systemic treatments, molecular and genetic testing, next-generation hormonal therapies, PSMA-targeted treatments, supportive care, survivorship, quality of life, and emerging clinical research.
By bringing together leading experts from different countries and healthcare systems, the congress aims to strengthen multidisciplinary collaboration, share real-world clinical experience, and support the development of more personalized and effective approaches to prostate cancer care worldwide.
Who Should Attend?
This congress is designed for medical oncologists, urologists, urologic oncologists, radiation oncologists, surgical oncologists, radiologists, pathologists, nuclear medicine specialists, oncology nurses, oncology pharmacists, genetic counselors, researchers, palliative care professionals, patient advocates, and all healthcare professionals involved in the diagnosis, treatment, and long-term care of patients with prostate cancer.
Why To Attend?
Prosto 2026 will provide a global platform for leading experts and multidisciplinary cancer care professionals to discuss the latest developments in prostate cancer screening, diagnosis, treatment, and survivorship.
Participants will gain practical insights into multidisciplinary decision-making, learn from real-world clinical experiences, explore biomarker-guided and personalized treatment approaches, and better understand the role of advanced imaging and innovative therapies across different stages of prostate cancer.
The congress will also offer opportunities to connect with international experts and join a global conversation focused on improving survival, quality of life, and long-term outcomes for patients with prostate cancer
Contact Us
Partnership & Collaboration Opportunities
Shushan Hovsepyan
Senior Vice President, OncoDaily
Email: shushan.hovsepyan@oncodaily.com
Phone: +1 571 775 9710
Event-Related Inquiries
Inessa Mkhitaryan
Head of Global Events, OncoDaily
Email: inessa.mkhitaryan@oncodaily.com
General Inquiries
Email: info@oncodaily.com
